Sarah B. Noonberg Marinus Pharmaceuticals, Inc. (MRNS) insider trading activity

MRNS Quotes by TradingView

Sarah B. Noonberg is of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,100 shares of MRNS, which is worth approximately $4,512. The most recent transaction as insider was on Jun 18, 2024, when has been sold 2,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.1K
0% 3M change
95.83% 12M change
Total Value Held $4,512

Sarah B. Noonberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Grant, award, or other acquisition
-
2,300 Added 14.02%
14,100 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
4,600 Added 28.05%
11,800 Common Stock
May 16 2023
BUY
Grant, award, or other acquisition
-
7,200 Added 50.0%
7,200 Common Stock

Also insider at

PRTA
PROTHENA CORP PUBLIC LTD CO Healthcare
Chief Medical Officer
PTGX
Protagonist Therapeutics, Inc Healthcare
Director
NLTX
Neoleukin Therapeutics, Inc. Healthcare
Director
MGX
Metagenomi, Inc.
Chief Medical Officer
SBN

Sarah B. Noonberg

South San Francisco, CA

Track Institutional and Insider Activities on MRNS

Follow MARINUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNS shares.

Notify only if

Insider Trading

Get notified when an Marinus Pharmaceuticals, Inc. insider buys or sells MRNS shares.

Notify only if

News

Receive news related to MARINUS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNS